ABSTRACT -Deltamethrin, a pyrethroid insecticide, used extensively for pest control has been reported to cause adverse health effects including carcinogenic/toxic effects in animals but the underlying mechanism remains elusive. In the present study, we investigated the effect of deltamethrin after short exposure on early protein expression changes involved in neoplastic transformation in mouse skin, validated the results in human keratinocyte HaCaT cells and thereby explore the possible underlying mechanism. Deltamethrin (4 mg/kg b.wt) and benzo[a]pyrene (B[a]P, 0.05 mg/kg b.wt) were topically applied on Swiss albino mice, respectively. The comparative protein expression profiles with vehicle control were generated by 2-dimensional gel electrophoresis (2-DE) and mass spectrometry. 2-DE maps of deltamethrin and B[a]P treated mouse skin showed 20 and 24 significant (2 fold change, p < 0.05) differentially expressed protein spots, against vehicle controls. However, comparison between them showed relatively similar expression level of 20 spots. Among them, 5 proteins (carbonic anhydrase III, peroxiredoxin-2, calcyclin, superoxide dismutase [Cu-Zn], ubiquitin) are of particular significance as these are involved in cancerrelated key processes. Deregulation of these was confirmed at protein and mRNA levels by immunoblotting and RT-PCR in mouse skin and HaCaT cells. Therefore, we conclude that these preliminarily identified proteins might be responsible for the neoplastic transformation of mouse skin epidermal cells and HaCaT cells by deltamethrin. This study proposes complementary mechanism where inhibition of proteasome activator protein (PA200) is responsible for accumulation of ubiquitinated-calcyclin, regulates deltamethrin-induced neoplastic changes in mouse skin and HaCaT cells.
INTRODUCTION
The ubiquitous nature of pesticide usage with minimal precautions has caused contamination of food, workplace, and the environment (Aprea et al., 1998; Cole et al., 1998) . Because of high insecticidal potency and relatively low mammalian toxicity pyrethroid insecticides are the maximum frequently used pesticides (Nasuti et al., 2008) . Though, definite pyrethroids are supposed to be having genotoxic/carcinogenic prospectives. Deltamethrin, a synthetic category II pyrethroid, first synthesized in 1974, has been extensively used in regulating insect pests of agricultural significance (Elliott et al., 1974; IPCS, 1990) . It is stated to cause several contrary effects in epidemiological and experimental studies. Clinical exhibitions of severe deltamethrin poisoning have been recognized in occupationally and accidentally exposed cases (He et al., 1989; Zhang et al., 1991) . Tests of certain deltamethrin products on mammals or insects tell remarkable neurotoxicity via stimulating voltage sensitive sodium channels (Vais et al., 2001; Shafer et al., 2005) . Maximum deltamethrin products continue for 1 to 2 weeks in the environment, with even shorter time in direct sunlight (ETN, 1995) . In mice, it is a potent oxidative stress-inducing agent (Rehman et al., 2006) , and also enormously toxic for all clusters of aquatic organisms (WHO, 1990) . Deltamethrin is defined to alter cell metabolism in diverse methods, with a potential 'indirect' genotoxic threat, including DNA damage and micronuclei induction in human lymphocytes and mouse bone marrow cells (Gandhi et al., 1995; Scassellati et al., 1996) . An amplified occurrence of lymphomas was witnessed in mice after deltamethrin administration through gavages at lesser doses, whereas a bigger occurrence of thyroid tumors was recorded in rats (Cabral et al., 1990) . Studies from our laboratory have also shown the mutagenic and skin tumor initiating potential of deltamethrin in mice (Shukla and Taneja, 2000; Shukla et al., 2001) .
Maximum toil has concentrated on the mutations and carcinogenesis persuaded by deltamethrin. Though, the molecular mechanism after its method of exploit is still unidentified. Consequently, concurrent amounts of transformed proteins can enable in understanding the mechanisms linked with carcinogenic reactions tempted by deltamethrin. Of lately, a swift progress of toxicoproteomic tools has added a lot in a comprehensive study of modifications in protein expression and alterations that are reactive to hostile environmental challenges (Wetmore and Merrick, 2004) . Amid the knowhow, two-dimensional gel electrophoresis (2-DE) united with mass spectrometry (MS) are extensively used to discrete and illustrate these changed proteins in biological systems (WittmannLiebold et al., 2006) . Consequently employing the 2-DE/ MS identification and protein expression confirmation in combination, the complete objective of this study is to examine the proteins linked with deltamethrin-induced neoplastic modifications in mouse skin, so as to better know the underlying mechanisms. To accomplish this goal, complete mouse skin proteome changes in answer to deltamethrin exposure were analyzed and the subsequent protein expression profile was equated with protein expression profiles of mouse skin exposed to well characterized carcinogen viz., benzo-[a]-pyrene (B[a]P, tumor initiator). We further prolonged the work to confirm our outcomes in human immortalized keratinocyte HaCaT cells. As the applicability of animal data to the human condition is not constantly forthright owing to species differences; therefore, we speculated that using human cells as experimental in vitro model will support in the calculation of human carcinogenicity. These are epithelial cells derived from adult human skin and show regular differentiation capacity unaffected by long-term cultivation and transformation (Boukamp et al., 1988) . Besides, these cells demonstrate better analytical results in contrast with keratinocyte and skin models, and they therefore, establish a suitable model for studying the mechanisms behind pesticides induced molecular changes (Ledirac et al., 2005) .
MATERIALS AND METHODS

Materials
Decis (Deltamethrin, 2.8% E.C.) was procured from Hoechst Agr-Evo. IPG strips and 0.5% pH 3-10 IPG buffer were purchased from Bio-Rad Laboratories (Hercules, CA, USA). B[a]P, CHAPS, DTT, iodoacetamide (IAA), urea, acrylamide, Bis, TEMED, tri-butyl phosphine (TBP), ammonium persulfate, phenylmethylsulfonylfluoride (PMSF) and β-actin were received from Sigma-Aldrich (St. Louis, MO, USA). DNase/RNase and protein molecular weight marker was bought from Bangalore Genei (Bangalore, India). The monoclonal carbonic anhydrous 3 (Ca 3), peroxiredoxin 2 (Prx 2), calcyclin, superoxide dismutase 1 [Cu-Zn] (Sod 1), and proteosome activator (PA200) antibodies were procured from Santa Cruz Biotechnology Inc, Europe and ubiquitin (P4D1) (Ub) antibody from Cell Signaling Technology (Beverly, MA, USA). The rest of the chemicals used in the study were of analytical grade of purity and procured locally.
Animals and treatments
Male Swiss albino mice (12-15 g body weight [b. wt.]) were taken from Indian Institute of Toxicology Research animal breeding colony and acclimatized for 1 week. The animal experiment was conducted after the approval by the institutional review board and conducted according to declaration of Helsinki principles. Animals were kept under standard laboratory conditions (temperature 23 ± 2ºC, relative humidity 55 ± 5%) and were fed with synthetic pellet basal diet (Ashirwad, Chandigarh, India) and tap water ad libitum. All the treatments were given in a single topical dose on the shaved dorsal region of the mice skin. They were divided into 3 groups of 4 animals each namely: Group І : Vehicle control (0.2 ml acetone) Group П : Deltamethrin (4 mg/kg b.wt in 0.2 ml acetone) (Shukla et al., 2001 ) Group Ш : B[a]P (0.05 mg/kg b.wt in 0.2 ml acetone)
After 24 hr, all the animals were sacrificed and their skin was excised and stored at -80°C (New Brunswick Scientific, Deutschland, Germany) until further use.
Sample preparation for 2-DE
The skin hair of vehicle control and treated animals was removed with a sharp scalpel blade, and fat was scrapped off, on ice. Small pieces of cleaned skin tissues (10%) were then homogenized individually in 2-DE lysis buffer containing 8 M urea, 4% CHAPS, 10 mM DTT, 0.5% pH 3-10 IPG buffer, 5 mM TBP, DNase/RNase and 1 mM PMSF. The lysed samples were sonicated for 10 sec for 3 strokes followed by a centrifugation at 13,000 rpm for 30 min at 4°C and pooled for the respective group. After quantification of proteins by the Bradford method, the supernatants were stored at -80ºC until use for 2-DE.
2-DE for differential protein expression
2-DE was performed as previously described (George et al., 2010) . Briefly, for each sample, an equivalent of 250 μg of solubilized proteins dissolved in 300 μl volume of rehydration solution (7 M urea, 2 M thiourea, 4% CHAPS, 65 mM DTT, 0.5% pH 3-10 IPG buffer and trace bromophenol blue) was loaded onto a 17 cm non-linear, IPG strips of pH 3-10 (Bio-Rad, Hercules, CA, USA). After rehydration, the strips were focused to total of 45.5 kVh (Protean IEF Cell, Bio-Rad). Once IEF was completed, the strips were equilibrated in 6 M urea, 2% SDS, 20% glycerol, 50 mM Tris-HCl, 0.01% w/v bromophenol blue containing 1% DTT, for 15 min with shaking in the first step, followed by 2.5% w/v IAA for an additional 15 min, in the second step. SDS-PAGE was performed using 12% polyacrylamide gel on Protean II xi electrophoresis equipment (Bio-Rad) and Tris-glycine-SDS (pH 8.3) as the electrode buffer, the gels were run at 15 mA/gel until the bromophenol blue dye marker had reached the bottom of the gel. Molecular weight marker was placed onto the gel by pipetting 8-10 μl onto a piece of blotting paper which was then loaded onto the gel surface. Each experiment was performed in triplicate to get the reproducible results.
Staining and image analysis
After completion of the second-dimension electrophoresis, the gels were fixed and stained by using neutral silver staining protocol (Rabilloud et al., 1994) . Images of silver stained gels were acquired using a Versa Doc Imaging System (Bio-Rad). Analysis of the gels including background subtraction, spots detection, volume normalization and differences in protein expression levels among samples were analyzed by using PDQuest software Ver. 7.4.0 (Bio-Rad). To determine the variation, three gels were prepared for each sample. The protein spots that varied 2 fold changes (either increase or decrease) in each of the test groups and a control group were manually labeled and considered for mass spectrometry (MS) analysis.
LC-MS/MS for protein identification
Differential protein spots of interest were excised manually by using pipette tips and washed 3 times with milli-Q water. Each spot was placed into a 1.5 ml microtube filled with milli-Q water. In-gel digestion for LC-MS/ MS analysis was performed at The Centre for Genomic Applications, New Delhi (India). In brief, trypsinized peptide samples (6 μl) were injected to Agilent 1100 NanoLC-1100 system (Agilent, Palo Alto, CA, USA), which comes combined with a microwell-plate sampler and thermostat column compartment for preconcentration (LC Packings, Agilent). The samples are loaded on the column (Zorbax 300SB-C18, 150 mm X 75 um, 3.5 um) using a pre-concentration step in a micro pre-column cartridge (Zorbax 300SB-C18, 5 mm X 300 um, 5 um). After 5 min, the pre-column is connected with the separating column, and multistep gradient (3% till 5 min, 15% for 5-8 min, 45% for 8-50 min, 90% for 50-55 min, 90% for 55-70 min, then again 3% for 71 min) is started. An LC/MSD Trap XCT with a nano-electrospary interface (Agilent) operated in the positive ion mode is used for MS. Ionization (1.5 kV ionization potential) is performed with a liquid junction and a non-coated capillary probe (New Objective, Cambridge, MA, USA). Calibration of the instrument is performed using the standard Agilent tune mix. Peptide ions are analyzed by the data-dependent method, the full MS scan. The scan sequence consists of 1 full MS scan followed by 4MS/ MS scans of the most abundant ions. Mass tolerance of 2Da and monoisotopic values of 50 ppm/100 ppm, were used for searching. The missed cleavage sites were allowed up to 1; the fixed modification was selected as carbamidomethylation (cysteine); the variable modification was selected as oxidation (methionine). Probability based MOWSE score was calculated in terms of ion score -10*Log (P), where P is the probability and observed match was considered as a random event. Data was analyzed using Agilent Ion Trap Analysis Software Version 5.2. Proteins were identified against the SWISS-PROT (GeneBio, Geneva, Switzerland) database (http:// www.matrixscience.com) using Mascot Daemon (Matrix Science, London, UK), a client attached to the Mascot search protocol.
Differential proteins verified by immunoblot analysis
The differential proteins, screened with 2-DE, were confirmed by immunoblotting. A total of 50 μg of total protein was resolved on 10-18% polyacrylamide gel. These samples were then electro-transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA, USA). After blocking with 5% nonfat dry milk, the membranes were immunoblotted with Prx 2, Ub, Sod 1, Ca 3, calcyclin and β-actin antibodies at dilutions recommended by the suppliers. Horse radish conjugated secondary antibodies and a chemiluminescence kit (Millipore) were used for detection. Protein expression was visual-ized by Versa Doc Imaging System (Bio-Rad). The intensity of the bands normalized to the band of β-actin was measured using software UNSCAN-IT automated digital system version 5.1 (Silk Scientific, Orem, UT, USA) and then given in terms of calculated quantitative fold change with respect to control.
For immunoblot detection of PA200, protein extracts (50 μg per sample) were fractionated on 5% polyacrylamide gels, blotted onto a PVDF membrane, probed and quantified as above described.
Cell culture conditions and treatments
HaCaT cells were purchased from National Centre for Cell Science, Pune, India. The cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum, 1% penicillin streptomycin (Gibco Lifetech, Karlsruche, Germany), and maintained in a humidified atmosphere of 95% O 2 and 5% CO 2 at 37°C. Deltamethrin and B[a]P were dissolved in DMSO and then diluted in medium to achieve the desired final concentrations while DMSO was used as vehicle control. The final volume of DMSO added to cells did not exceed 0.5% (v/v). Deltamethrin (3 μg/ml) exposure was given for 24 hr duration while B[a]P (0.025 μg/ml) exposure was for 30 min. To evaluate the dose-response effect of delatmethrin (0.5-10 μg) on the growth and proliferation of HaCaT cells, the MTT assay was performed for 24 hr (data not shown).
Cell lysates preparation
Following treatment of the cells, the medium was aspirated and the cells were washed twice with cold phosphate buffer saline (10 mM, pH 7.4) and disrupted on ice in RIPA lysis buffer. The cells were scraped, and the lysate was collected in a microfuge tube and passed through a 21G needle to break up the cell aggregates. The lysates were cleared by centrifugation at 14,000 g for 15 min at 4ºC and the supernatant (total cell lysate) was either used immediately for immunoblotting or stored at -80ºC.
RNA isolation from mouse skin/HaCaT cells
Total RNA was extracted from tissue samples/cell culture using the TRIzol system (Sigma, St. Louis, MO, USA), in accordance with the manufacturer's instructions. RT-PCR was conducted using the previously described method (Arora et al., 2006) . Briefly, cDNA was prepared from RNA samples (3-5 μg) to which 1 μg oligo(dT) 18 , 0.5 mM dNTP, and 200 U of Revert Aid TM H Minus M-MuL V RT enzyme (MBI Fermentas, Hanover, MD, USA) were added. Specific primers for the proteins of interest (listed in Table 1 ) were synthesized at Bangalore Genei (Bangalore, India). The PCR products identified by 2% agarose gel electrophoresis were analyzed using IS1000 image analysis system (Alpha Innotech, San Leandro, CA, USA). All samples were analyzed in triplicate. The housekeeping gene β-actin was used as an internal control.
Statistical analysis
Protein expression data for vehicle control and treated groups has been shown in terms of mean ± S.D. of 3 replicate gels for fold-changes of normalized spot volumes. For the statistical analysis of these and other data, Student-t-test was applied, and p < 0.05 was considered as significant.
RESULTS
Alterations in protein expression profiles
Protein expression profiles were studied in mouse skin after optimizing the conditions for protein extraction and 2-DE analysis (George et al., 2010) . Alterations of proteins was tested in three replicate gels after 24 hr of deltamethrin and B[a]P exposure. Proteins from three independent replication samples of vehicle control, deltamethrin-treated, and B[a]P-treated were extracted and resolved on 17 cm IPG gels (Fig. 1A) . Using PDQuest 7.4.0 2-DE gels analysis software, ~500-700 protein spots were detected in each gel. Spots that showed at least two times increased or decreased protein expression (p < 0.05) in the two treated groups, when compared to the vehicle control, were selected for protein identification using a MS approach (Fig. 1A) . In comparison to the control group, 20 spots in deltamethrin-treated and 24 spots in B[a]P-treated groups displayed differential expression. Among these 23 protein spots with expression changes, 19 were successfully identified by LC-MS/MS analysis. The remaining 4 spots could not be successfully identified, mainly because the abundance of the protein was too low to produce a spectrum, or the score of database searching was not high enough to yield unambiguous results. The preliminarily identified proteins were categorized according to their molecular functions (Table 2) as given in the SWISS-PROT database. Correlation analysis among pairs of vehicle control with deltamethrin and B[a]P showed average correlation coefficients of 0.43 and 0.57. However, no significant variation in protein expression pattern was recorded among pair of delatamethrin and B[a]P with average correlation coefficient of 0.93 (Fig. 1B) .
Comparison between the gels of deltamethrin and B[a]P revealed that 20 spots (1, 3, 4, 5, 6, 8, 9, 10, (2) (3) 11, 11, 12, 14, 15, 16, 18) were showing similar expression profiles in both groups. Out of these, 11 spots (1,2-1, 3,4,5,6,8, 9,2-2,2-3,16) were overexpressed, 1 spot (12) was under-expressed, and 8 spots (10, 14, 15, 18) were unique in both the groups (Table 2) . Among them, we focused mainly on the 5 proteins involved in the cancer-related process like apoptosis and growth-inhibition, anti-oxidation, protein folding, stress response, calcium binding and protein biosynthesis processes. These proteins are Ca 3 (spot no.2), Prx 2 (spot no.4), calcyclin (spot no.8), Sod 1 (spot no.10) and Ub (spot no.16). Fig. 2 shows the closeup views of these protein spots, Table 2 and histogram (Fig. 3) shows the variation pattern and fold-change of these selected proteins. A number of identified proteins are presented by multiple spots such as albumin, peptidylprolyl isomerase and lectin which may be the result of phosphorylation/dephosphorylation, glycosylation or other post-translational modification as well as alternative splicing of mRNA.
Identification and immunoblot verification
To confirm and validate the identified spots, the expression levels of Ca 3, Prx 2, calcyclin, Sod 1, free Ub/Ub conjugates proteins in mouse skin tissues were analyzed by immunoblotting with the respective antibodies. As shown in Fig. 3A , decreased expression of Sod 1 and increased expression of Ca 3, Prx 2, free Ub and an intense 10 kDa band of ubiquitinated-calcyclin was observed in the immunoblot of the deltamethrin and B[a] P-exposed groups as compared to the vehicle control. Thus, we have also confirmed the increased expression of total calcyclin in deltamethrin and B[a]P-exposed groups over the control group (Fig. 4A) . These expression patterns of the selected proteins were found to be consistent with those in 2-DE gel images.
Because inhibition of proteasome function is responsible for accumulation of ubiquitinated-proteins, therefore the effect of deltamethrin on the levels of PA200 (~200 kDa) that activates the 26S proteasome complex was further analyzed (Ustrell et al., 2002) . A more pronounced decrease in the levels of PA200 protein was observed in the immunoblot of the deltamethrin and B[a]P-exposed groups as compared to the vehicle control (Fig. 4A) . We further extended this work to confirm and validate the expression levels of Ca 3, Prx 2, Sod 1, total calcyclin, free Ub/ubiquitinated-proteins and PA200 in human keratinocyte, HaCaT cells, by immunoblotting. As shown in Fig. 4B , in vitro results were similar to in vivo results.
Gene expression analysis
The expression of Ca 3, Prx 2, Sod 1, calcyclin and Ub proteins was also confirmed at mRNA level using RT-PCR, in both mouse skin and HaCaT cells, and the expression pattern was comparable with protein expression patterns of both mouse skin and HaCaT cells treated with deltamethrin and B[a]P. A significant decrease (p < 0.05) in Sod 1 and an increase in Ca 3, Prx 2, Sod 1, calcyclin and Ub was also observed at mRNA level, in both deltamethrin and B[a]P-exposed mouse skin and HaCaT cells, as against the vehicle control (Figs. 5A and 5B).
DISCUSSION
United States Environmental Protection Agency has classified deltamethrin as "Not likely to be a human carcinogen" (USEPA, 2004) . However, previous study from our lab reported tumor initiating potential of deltamethrin in the single dose initiated mice (4 mg/kg b. wt) (Shukla et al., 2001) . Nevertheless, there is little existing knowledge about the mechanism of its carcinogenic potential. Therefore, using proteomic platform we have investigated the early protein signatures induced by deltamethrin after short-term exposure on mouse skin for the better understanding of the molecular biological defects, behind its carcinogenic activity. From the comparative 2-DE analysis of deltamethrin-treated, B[a]P-treated, and of the vehicle (acetone)-treated mouse skins, we found ~500-700 protein spots in each gel. Among them, 20 spots in deltamethrin-treated and 24 spots in B[a]P-treated samples showed a 2-fold change (either increase or decrease) in comparison to the vehicle control mouse skin and out of these, 20 spots were showing similar expression profile patterns in both of them. Five among them, namely, Ca 3, Prx 2, Sod 1, calcyclin and Ub appeared to be of particular significance since the database search for these altered proteins indicated their possible roles in apoptosis and growth-inhibition, protein folding, anti-oxidation, stress response, calcium binding and protein biosynthesis processes.
Ca 3 and Prx 2 showed an increase in both the deltamethrin-exposed and B[a]P-exposed conditions (Fig. 2, Table 2 ). Ca 3 is a cytoplasmic enzyme, which is abundant in the liver as well as in the red skeletal muscle, and plays a role in the cellular response to oxidative stress and is a common mediator of apoptosis (Cotgreave and Gerdes, 1998) . Ca 3 over-expression has been known to protect cells from hydrogen peroxide-induced apoptosis (Raisanen et al., 1999) . Over-expression of Ca 3 also resulted in increased anchorage-independent growth and invasiveness in hepatoma cells through FAK signaling pathway (Dai et al., 2008) . Peroxiredoxins (Prxs) are a family of antioxidant enzymes known as scavengers of peroxide in mammalian cells and some of them affect cell differentiation and apoptosis (Immenschuh and Baumgart-Vogt, 2005). Prx 2, one of the Prxs family member has been known to reduce hydrogen peroxide and other reactive oxygen species (ROS), using thioredoxin as the immediate electron donor (Chae et al., 1994 (Chae et al., , 1999 , and its peroxidase activity prevents cells from ROS insult. Prx 2 is also involved in the cellular signaling pathways of growth factors and tumor necrosis factor-α, by virtue of its regulation of intracellular hydrogen peroxide (Kang et al., 1998; Sen, 1998) . Some studies have reported the over-expression of Prx 2 in some kind of car- cinomas, indicating that Prx 2 has a proliferative effect and may be related to cancer development or progression (Kinnula et al., 2002; Lee et al., 2003; Lehtonen et al., 2004; Kim et al., 2009) . Recently, we have also shown the over-expression of these two proteins in mouse skin treated with glyphosate and 12-O-tetradecanoylphorbol-13-acetate (George et al., 2010) . Sod 1 is an abundant enzyme found in the cytoplasm that converts superoxide into hydrogen peroxide and molecular oxygen. High expression levels of Sod 1 were accompanied by increased activities of antioxidant enzymes, catalase, glutathione reductase, and glutathione, resulting in suppression of UVB-induced cell apoptosis, suggesting a collaborative role in protecting keratinocytes from oxidative stress (Takahashi et al., 2000) . Deltamethrin is known to inhibit the activity of Sod 1 in mice erythrocytes (Yarsan et al., 2002) . Sod 1 down-regulation as a result of both deltamethrin and B[a]P exposure, was observed in this study, which indicates their role in carcinogenesis (Fig. 2, Table 2 ). Decreased Sod activity has also been reported in a wide range of tumors earlier (Kensler et al., 1983; Egner and Kensler, 1985) .
In this study, one altered Ca 2+ binding protein, calcyclin was also identified in response to deltamethrin and B[a]P exposure. Calcyclin (S100A6), one of the S100 family proteins is a well-established marker of melanoma cells in which its level correlates with tumor invasiveness and poor prognosis (Weterman et al., 1992) . Also, the up-regulation of calcyclin has been reported in a variety of cancers (Yang et al., 2007a, 2007b; Luo et al., 2008; Fullen et al., 2008) . The other significantly up-regulated protein at 24 hr exposure of deltamethrin and B[a]P, identified by 2-DE and MSsequencing, was Ub, a ~9-kDa protein, known to be responsible for the regulation of intracellular protein metabolism (Hershko et al., 1980) . Benzo[a]pyrene diol epoxide, metabolic active form of B[a]P has been previously reported to up-regulate deubiquitinating enzyme (UCHL3) in human amniotic epithelial that hydrolyzes C-terminal esters and amides of Ub leading to the generation of monomeric Ub (Shen et al., 2008) . Conjugation of Ub to target proteins serves as a signal for selective degradation of abnormal, damaged and short-lived proteins under stressful conditions by proteasomal degradation pathway (Parag et al., 1987; Bachmair and Varshavsky, 1989; Chau et al., 1989) . Ub also appears to be involved in several other vital processes, such as DNA repair, cell cycle control, modulation of cell surface receptors, and processing of major histo-compatibility complex class I antigen (Glotzer et al., 1991; Cenciarelli et al., 1992; Mori et al., 1993; Rock et al., 1994) . The selective degradation or stabilization of intracellular proteins by Ub-dependent pathways is essential for regulation of many cellular processes. Interestingly, our immunoblotting results show an up-regulated 9 kDa protein band i.e free Ub and one intense 10 kDa ubiquitinated protein band. This was found by using antibody specific for detection of free Ub and Ub congugated proteins, in the two treatments. The possibility of a cross reaction between the anti-Ub antibody used and calcyclin protein can be discounted eas- ily because a specific anti-Ub antibody also reacted with this 10 kDa band. Moreover, ubiquitination of this 10 kDa band was also evident through increased expression of total calcyclin protein. These findings support the possible conjugation and accumulation of calcyclin with Ub in deltamethrin and B[a]P-treated mouse skin. Calcyclin is a protein with a theoretical mass of 10.179 kDa and has been proposed as a regulator of protein ubiquitination through its interaction with calcyclin-binding protein/Siah-1-interacting protein, which forms part of a novel Ub ligase complex involved in β-catenin degradation (Nowotny et al., 2003) . Moreover, here we provide the first evidence, based not only on the detection of free Ub/ ubquitinated-calcyclin, but mostly on a functional analysis of the PA200 responsible for the proper functioning of proteasomal degradation system and turnover of ubiquitinated-calcyclin that the ubiquitination system is strongly involved in the early phases of deltamethrin-induced neoplastic changes in mouse skin and HaCaT cells. The data obtained from gene expression analysis provided confirmatory evidence that expression of Ub and calcyclin was altered at transcriptome level by deltamethrin and B[a]P, respectively (Fig. 4) . Our next objective was to investigate whether these in vivo findings could also be translated to an in vitro situation. Our results clearly demonstrated that both deltamethrin and B[a]P modulated the protein expression levels of Ca 3, Prx 2, Sod 1, calcyclin and Ub and PA200 in HaCaT cells, too. Studies show that these proteins are modulated in HaCaT cells on viral infection (Lee et al., 2005) and radiation induced oxidative stress (Isoir et al., 2006) as well as in other cutaneous tumor cells (Brinck et al., 1995) . In parallel, related gene expression levels of Prx 2, Ub, Sod 1, Ca 3 and calcyclin are also showing similar expression levels in HaCaT cells.
In conclusion, several proteins were identified that displayed similar differential expression levels in mice skin following deltamethrin and B[a]P exposure. Of those, 5 specific proteins (Ca 3, Prx 2, Sod 1, calcyclin and Ub) play a role in relevant processes like growth, differentiation and apoptosis. Disturbance of these processes plays an crucial role in carcinogenesis. These findings suggest that these preliminarily identified proteins can be useful as candidate biomarkers involved in the onset of neoplastic changes. However, further functional analyses of these proteins can give more information on their physiological roles in tumor etiology, a critical requirement for proper risk assessment. Mechanistic studies show that downregulation of PA200 thus resulting in inhibition of proteasome function and upregulation of Ub/ubiquitinated-calcyclin/total calcyclin was present both in deltamethrin and B[a]P groups and not in the vehicle control group. This supports that ubiquitination process might be involved in deltamethrin-induced neoplastic changes in both mouse and human skin (Fig. 6) .
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